EKSO logo

Ekso Bionics Holdings, Inc. (EKSO)

Profile

Full Name

Ekso Bionics Holdings, Inc.

Ticker

NASDAQ: EKSO

Exchange

NASDAQ

Sector

Healthcare

Industry

Medical Instruments & Supplies

Country

United States

IPO

January 17, 2014

Indexes

Not included

Website

https://www.eksobionics.com

Employees

61

Key Details

Price

$5.46(-1.80%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$17.93M(-1.94% YoY)

Annual EPS

-$8.43(-669.13% YoY)

PE Ratio

-

Next earnings date

Mar 2, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $5.46
    EKSO price is $5.46

    30-Day Relative Volume

    0.16
    EKSO 30-day relative volume is 0.16

    Price Performance

    Price 1-Day Change

    -1.8%
    EKSO price is down -1.8% today

    Price YTD Change

    -40.33%
    EKSO price is down -40.33% since January 1st

    Price 1-Year Change

    -43.91%
    EKSO price is down -43.91% year-on-year

    Price 3-Year Change

    -70.07%
    EKSO price is down -70.07% over the past 3 years

    Price Range

    Price All-Time High

    $12946.50
    EKSO price is currently -99.96% below its historical high of $12946.50

    Price 3-Year Low

    $2.73
    EKSO price is currently +100.00% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $14.26M
    EKSO market cap is $14.26 million

    Market Cap 3-Year Change

    -10.77%
    EKSO market cap is down -10.77% over the past 3 years

    Market Cap All-Time High

    $777.14M
    EKSO market cap is currently -98.17% below its historical high of $777.14 million

    Market Cap Sector Percentile

    21.67%
    EKSO market cap is higher than 21.67% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +78.09%
    EKSO shares outstanding is up +78.09% year-on-year

    Shares Outstanding 3-Year Change

    +198.08%
    EKSO shares outstanding is up +198.08% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.99
    EKSO beta is 0.99

    200-day SMA

    $4.74
    EKSO price is currently +15.12% above its 200-day simple moving average

    50-day SMA

    $4.77
    EKSO price is currently +14.37% above its 50-day simple moving average

    14-Day RSI

    66.41
    EKSO 14-day relative strength index is 66.41

    Volume

    0.16
    EKSO 30-day relative volume is 0.16

    ATR

    $0.35
    EKSO average true range is $0.35

    10-day Historical Volatility

    42.09%
    EKSO 10-day historical volatility is 42.09%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $17.93M
    EKSO annual revenue is $17.93 million

    Revenue Analysts Estimate

    $14.71M
    EKSO annual revenue is currently +21.90% higher than the consensus analysts' forecast

    Revenue 1-Year Change

    -1.94%
    EKSO annual revenue is down -1.94% year-on-year

    Revenue Sector Percentile

    51.99%
    EKSO annual revenue is higher than 51.99% of companies in Healthcare sector

    EPS

    EPS

    -$8.43
    EKSO annual earnings per share is -$8.43

    EPS Analysts Estimate

    -$2.17
    EKSO annual earnings per share is currently -288.47% lower than the consensus analysts' forecast

    EPS 1-Year Change

    -669.13%
    EKSO annual earnings per share is down -669.13% year-on-year

    EPS Sector Percentile

    16.67%
    EKSO annual earnings per share is higher than 16.67% of companies in Healthcare sector

    Profit

    Gross Profit

    $10.24M
    EKSO annual gross profit is $10.24 million

    Gross Margin

    57.13%
    EKSO annual gross profit margin is 57.13%

    Operating Profit

    -$10.46M
    EKSO annual operating income is -$10.46 million

    Operating Margin

    -58.35%
    EKSO annual operating profit margin is -58.35%

    Net Income

    -$11.33M
    EKSO annual net profit is -$11.33 million

    Net Margin

    -63.21%
    EKSO annual net profit margin is -63.21%

    Expenses

    Total Expenses

    $29.25M
    EKSO annual total expenses is $29.25 million

    Operating Expenses

    $20.70M
    EKSO annual total operating expenses is $20.70 million

    Cost Of Goods Sold

    $7.68M
    EKSO annual cost of goods sold is $7.68 million

    Selling, General & Administrative Expenses

    $16.10M
    EKSO annual SG&A is $16.10 million

    Depreciation & Amortization

    $1.61M
    EKSO annual D&A is $1.61 million

    Interest Expense

    $0.00
    EKSO annual interest expense is $0.00

    Income Tax

    $0.00
    EKSO annual income tax is $0.00

    EBIT & EBITDA

    EBIT

    -$10.46M
    EKSO annual earnings before interest & taxes is -$10.46 million

    EBITDA

    -$8.85M
    EKSO annual EBITDA is -$8.85 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $26.65M
    EKSO annual total assets is $26.65 million

    Non Current Assets

    $7.81M
    EKSO annual long term assets is $7.81 million

    Current Assets

    $18.84M
    EKSO annual total current assets is $18.84 million

    Cash and Cash Equivalents

    $6.49M
    EKSO annual cash & cash equivalents is $6.49 million

    Accounts Receivable

    $7.24M
    EKSO annual accounts receivable is $7.24 million

    Inventory

    $4.57M
    EKSO annual inventory is $4.57 million

    Liabilities

    Total Liabilities

    $13.95M
    EKSO annual total liabilities is $13.95 million

    Long Term Liabilities

    $6.41M
    EKSO annual total long term liabilities is $6.41 million

    Current Liabilities

    $7.54M
    EKSO annual current liabilities is $7.54 million

    Accounts Payable

    $1.55M
    EKSO annual accounts payable is $1.55 million

    Debt

    Total Debt

    $5.98M
    EKSO annual total debt is $5.98 million

    Total Debt 1-Year Change

    -16.53%
    EKSO annual total debt is down -16.53% year-on-year

    Long Term Debt

    $4.31M
    EKSO annual long term debt is $4.31 million

    Short Term Debt

    $1.68M
    EKSO annual short term debt is $1.68 million

    Equity & Capital

    Shareholders Equity

    $12.71M
    EKSO annual stockholders equity is $12.71 million

    Book Value

    $190.60M
    EKSO annual book value is $190.60 million

    Retained Earnings

    -$250.47M
    EKSO annual retained earnings is -$250.47 million

    Working Capital

    $11.31M
    EKSO annual working capital is $11.31 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    -$9.85M
    EKSO annual cash from operations is -$9.85 million

    Cash From Operations 1-Year Change

    +18.32%
    EKSO annual cash from operations is up +18.32% year-on-year

    Cash From Investing

    -$37.00K
    EKSO annual cash from investing is -$37.00 thousand

    Cash From Investing 1-Year Change

    +76.43%
    EKSO annual cash from investing is up +76.43% year-on-year

    Cash From Financing

    $7.77M
    EKSO annual cash from financing is $7.77 million

    Cash From Financing 1-Year Change

    +2132.47%
    EKSO annual cash from financing is up +2132.47% year-on-year

    CAPEX

    CAPEX

    $37.00K
    EKSO annual capital expenditures is $37.00 thousand

    CAPEX 1-Year Change

    -76.43%
    EKSO annual capital expenditures is down -76.43% year-on-year

    Free Cash Flow

    Free Cash Flow

    -$9.88M
    EKSO annual free cash flow is -$9.88 million

    Free Cash Flow 1-Year Change

    +19.06%
    EKSO annual free cash flow is up +19.06% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    57.13%
    EKSO annual gross profit margin is 57.13%

    Operating Margin

    -58.35%
    EKSO annual operating profit margin is -58.35%

    Net Margin

    -63.21%
    EKSO annual net profit margin is -63.21%

    ROA & ROE

    ROA

    -40.78%
    EKSO annual return on assets is -40.78%

    ROE

    -89.52%
    EKSO annual return on equity is -89.52%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    EKSO price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    EKSO price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    1.47
    EKSO price to book ratio is 1.47

    PB Ratio Sector Percentile

    44.11%
    EKSO price to book ratio is higher than 44.11% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    0.97
    EKSO price to sales ratio is 0.97

    PS Ratio Sector Percentile

    22.44%
    EKSO price to sales ratio is higher than 22.44% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $16.49M
    EKSO enterprise value is $16.49 million

    Enterprise Value Sector Percentile

    25.73%
    EKSO enterprise value is higher than 25.73% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -1.73
    EKSO EV/EBITDA is -1.73

    EV/EBITDA Sector Percentile

    40.34%
    EKSO EV/EBITDA is higher than 40.34% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    2.50
    EKSO annual current ratio is 2.50

    Quick Ratio

    1.89
    EKSO annual quick ratio is 1.89

    Leverage

    Debt To Equity

    0.47
    EKSO annual debt to equity ratio is 0.47

    Interest Coverage Ratio

    -
    EKSO annual interest coverage ratio value is unknown

    Risk & Stability

    F-Score

    3
    EKSO piotroski f-score is 3

    Altman Z-Score

    -12.66
    EKSO altman z-score is -12.66

    Analyst ratings

    Recent major analysts updates

    Nov 18, 25 HC Wainwright & Co.
    Buy
    Jul 29, 25 Lake Street
    Buy
    May 6, 25 HC Wainwright & Co.
    Buy
    Mar 4, 25 Lake Street
    Buy
    Mar 4, 25 HC Wainwright & Co.
    Buy
    Jan 14, 25 HC Wainwright & Co.
    Buy
    Oct 29, 24 Lake Street
    Buy
    Oct 29, 24 HC Wainwright & Co.
    Buy
    Jul 30, 24 HC Wainwright & Co.
    Buy
    Jun 24, 24 Lake Street
    Buy

    Institutional Ownership

    Screeners with EKSO included

    Growing Shares Outstanding
    US stocks
    Best performing stocks last month
    Most recommended stocks
    NASDAQ Dividend Calendar
    Stocks below analysts price target
    Healthcare sector
    All stocks
    NASDAQ Listed Companies
    Ex Dividend dates calendar
    • What is the ticker symbol for Ekso Bionics Holdings, Inc.?
    • Does Ekso Bionics Holdings, Inc. pay dividends?
    • What sector is Ekso Bionics Holdings, Inc. in?
    • What industry is Ekso Bionics Holdings, Inc. in?
    • What country is Ekso Bionics Holdings, Inc. based in?
    • When did Ekso Bionics Holdings, Inc. go public?
    • Is Ekso Bionics Holdings, Inc. in the S&P 500?
    • Is Ekso Bionics Holdings, Inc. in the NASDAQ 100?
    • Is Ekso Bionics Holdings, Inc. in the Dow Jones?
    • When was Ekso Bionics Holdings, Inc.'s last earnings report?
    • When does Ekso Bionics Holdings, Inc. report earnings?

    What is the ticker symbol for Ekso Bionics Holdings, Inc.?

    The ticker symbol for Ekso Bionics Holdings, Inc. is NASDAQ:EKSO

    Does Ekso Bionics Holdings, Inc. pay dividends?

    No, Ekso Bionics Holdings, Inc. does not pay dividends

    What sector is Ekso Bionics Holdings, Inc. in?

    Ekso Bionics Holdings, Inc. is in the Healthcare sector

    What industry is Ekso Bionics Holdings, Inc. in?

    Ekso Bionics Holdings, Inc. is in the Medical Instruments & Supplies industry

    What country is Ekso Bionics Holdings, Inc. based in?

    Ekso Bionics Holdings, Inc. is headquartered in United States

    When did Ekso Bionics Holdings, Inc. go public?

    Ekso Bionics Holdings, Inc.'s initial public offering (IPO) was on January 17, 2014

    Is Ekso Bionics Holdings, Inc. in the S&P 500?

    No, Ekso Bionics Holdings, Inc. is not included in the S&P 500 index

    Is Ekso Bionics Holdings, Inc. in the NASDAQ 100?

    No, Ekso Bionics Holdings, Inc. is not included in the NASDAQ 100 index

    Is Ekso Bionics Holdings, Inc. in the Dow Jones?

    No, Ekso Bionics Holdings, Inc. is not included in the Dow Jones index

    When was Ekso Bionics Holdings, Inc.'s last earnings report?

    Ekso Bionics Holdings, Inc.'s most recent earnings report was on October 28, 2025

    When does Ekso Bionics Holdings, Inc. report earnings?

    The next expected earnings date for Ekso Bionics Holdings, Inc. is March 2, 2026
    On this page